Liver and biliary tract cancer trials in Taiwan

In Taiwan 54 Also abroad 1314

54 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Where
Chiayi City, Taipei
Age
18 years to 100 years
People
104 worldwide
Run by
CatalYm GmbH
See details and how to joinNCT07219459 · EU 2025-520675-86-00
Phase 3Taking people
D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
Where
Kaohsiung City
Age
18 years and over
People
240 worldwide
Run by
InnoPharmax Inc.
See details and how to joinNCT06622057
Phase 2Not yet taking people in Taiwan
Daraxonrasib in Asian RAS-mutant Biliary Tract Cancer
Where
Kaohsiung City
Age
18 years and over
People
55
Run by
National Health Research Institutes, Taiwan
See details and how to joinNCT07908550
Phase 1/2Taking people
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Where
Taichung, Tainan, Taipei, Taoyuan
Age
18 years and over
People
220 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00
Phase 2Taking people
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Where
Taipei
Age
18 years and over
People
750 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00
No phaseTaking people
Observational Study Protocol: LIVER-R
Where
Kaohsiung City, Taichung, Taipei, Taoyuan City
Age
18 years to 130 years
People
4,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT06252753
Phase 3Taking people
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Where
Kaohsiung City, Tainan, Taipei, Taoyuan
Age
18 years and over
People
286 worldwide
Run by
Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00
Phase 2Not yet taking people in Taiwan
An Exploratory Study of Single-Dose Neoadjuvant Nivolumab Without Surgical Delay in Patients With Resectable HCC
Where
Hsinchu, Taipei
Age
18 years and over
People
40
Run by
National Taiwan University Hospital
See details and how to joinNCT07902258
Phase 1/2Taking people
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Where
Taichung, Tainan, Taipei
Age
18 years and over
People
680 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00
Phase 1/2Taking people
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Where
Taichung, Tainan, Taipei
Age
18 years and over
People
198 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07291076 · EU 2025-523602-33-00
Phase 1/2Taking people
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Where
Kaohsiung City, New Taipei City, Taipei, Taoyuan
Age
18 years and over
People
862 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT05914116
Phase 1Taking people
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Where
Kaohsiung City, Taichung, Taipei, Taoyuan City
Age
18 years and over
People
325 worldwide
Run by
AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00
Phase 1/2Taking people
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Where
Taipei, Taoyuan
Age
18 years and over
People
304 worldwide
Run by
AstraZeneca
See details and how to joinNCT06795022 · EU 2024-516698-56-00
Phase 1Taking people
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Where
Taipei
Age
18 years and over
People
125 worldwide
Run by
Tyra Biosciences, Inc
See details and how to joinNCT06915753
Phase 3Taking people
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Where
Kaohsiung City, Taichung, Taipei, Taoyuan
Age
18 years to 99 years
People
620 worldwide
Run by
AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00
Phase 3Taking people
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Where
Changhua, Kaohsiung City, Taichung, Tainan, Tainan County, Taipei, Taoyuan
Age
18 years and over
People
1,220 worldwide
Run by
AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00
Phase 1/2Taking people
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Where
Taichung, Tainan, Taipei
Age
18 years and over
People
138 worldwide
Run by
Pfizer
See details and how to joinNCT07227012 · EU 2025-523525-17-00
Phase 1Taking people
A Study of ZW251 in Participants With Advanced Solid Tumors
Where
Taipei
Age
18 years and over
People
140 worldwide
Run by
Zymeworks BC Inc.
See details and how to joinNCT07164313
Phase 2Taking people
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
Where
Taoyuan City
Age
18 years and over
People
45
Run by
Chang Gung Memorial Hospital
See details and how to joinNCT06339424
No phaseTaking people
Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy
Where
Taoyuan City
Age
18 years and over
People
300
Run by
Chang Gung Memorial Hospital
See details and how to joinNCT06379256
Phase 2Taking people
Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
Where
Taoyuan City
Age
18 years and over
People
45
Run by
Chang Gung Memorial Hospital
See details and how to joinNCT06999694
Phase 2Taking people
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
Where
Taoyuan City
Age
18 years and over
People
45
Run by
Chang Gung Memorial Hospital
See details and how to joinNCT06999707
Phase 2Taking people
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Where
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
Age
18 years and over
People
226 worldwide
Run by
AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00
Phase 2Taking people
Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab
Where
Taoyuan City
Age
18 years and over
People
45
Run by
Chang Gung Memorial Hospital
See details and how to joinNCT06605664
Phase 3Taking people
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Where
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
Age
18 years and over
People
1,100 worldwide
Run by
AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00